Publications
Unreliable Charts in Economic Consulting
“A chart, to put it simply, conveys informaon. Nevertheless, a chart built on faulty analysis results in unreliable informaon.”
“The Accelerated Approval Program: Desiderata for a Proper Solution to the Untimely Completion of Confirmatory Trials,” Update Magazine, Food and Drug Law Institute, Winter 2023.
"Create An Economic Incentive For The Timely Completion Of Confirmatory Trials", Health Affairs Forefront. doi: 10.1377/forefront.20230727.205048
“Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearances
.” JAMA. 2023;329(18):1609.
“Recent Trends in Multiple First Generic Drug Filings,” Law360.com, March 13, 2023.
“Orphan Drug Approval Takeaways From Recent FDA Data,” Law360.com, January 14, 2022
“How Citizen Petitions Influence FDA Drug Approvals,” Law360.com, August 5, 2021.
“Shifting Trends in Marketing Approvals of Orphan Drugs,” Law360.com, June 3, 2021.
“Mapping the Predicate Chain for Medical Device Approval,” Law360.com, April 20, 2021.
“A look at Factors Influencing Medical Device Approval Speed,” Law360.com, February 5, 2021.
Additional Publications
“Missed Opportunity: Promoting Diversity Downstream,” noticias 2021 HNBA/VIA Annual Convention, 2021. [PDF]
2020 Annual Review of Antitrust Law Developments, American Bar Association Section of Antitrust Law, 2021.
“Mapping the Predicate Chain of 510(k) Devices, Emerging Health Knowledge Share, April 2021 [PDF]
“An Algorithm for 510(k) Clearance Times 1996-2020,” Emerging Health Knowledge Share, January 26, 2021. [PDF]
“FDA, USPTO Data Show Earlier Small-Molecule Drug Patenting,” Law360.com, December 16, 2020. [PDF]
“Is There a Patent Race in Small-Molecule Pharmaceuticals?” NERA Economic Consulting White Paper, November 16, 2020.
“How Orange Book Listings Affect Patent Density, Exclusivity,” Law360.com, August 12, 2020. [PDF]
“What the Orange Book Reveals About Trends in Patent Density, Evergreening, and Exclusivity,” NERA Economic Consulting White Paper, June 26, 2020.
“Antitrust Considerations for Biosimilar Reverse Payment Litigation – Not So Similar Afterall?” The Civil Practice & Procedure Committee’s Young Lawyers Advisory Panel: Perspectives in Antitrust, 8(3), May 2020. [PDF]
2019 Annual Review of Antitrust Law Developments, American Bar Association Section of Antitrust Law, 2020.
“Glossary of Pharmaceutical Terms and Acronyms,” NERA Economic Consulting White Paper, June 13, 2019.
“Effects of Antenatal Testing Laws on Infant Mortality,” Journal of Health Economics, 45, 2016.
“Marriage and divorce: patterns by gender, race, and educational attainment,” Monthly Labor Review, October 2013.
“Measuring Personality Traits and Predicting Default with Experiments and Surveys” in Banking the World, edited by Jonathan Murdoch, Robert Cull, and Asli Demirguc-Kunt, MIT Press, 2012.
“Iodine Deficiency and Schooling Attainment in Tanzania,” American Economic Journal: Applied Economics, 1(4), 2009.